T1	Outcomes 67 124	long-term prognosis of advanced nasopharyngeal carcinoma.
T2	Outcomes 158 196	safety, efficacy, and 6-year follow-up
T3	Outcomes 758 787	adverse events and responses.
T4	Outcomes 796 821	rAd-p53-specific p53 mRNA
T5	Outcomes 920 936	p21/WAF1 and Bax
T6	Outcomes 959 993	vascular endothelial growth factor
T7	Outcomes 1039 1061	Complete response rate
T8	Outcomes 1263 1301	5-year locoregional tumor control rate
T9	Outcomes 1374 1440	5-year overall survival rate and 5-year disease-free survival rate
T10	Outcomes 1583 1623	dose-limiting toxicity or adverse events
T11	Outcomes 1645 1660	transient fever
T12	Outcomes 1736 1765	safe and biologically active.
T13	Outcomes 1810 1858	radiotherapeutic tumor control and survival rate
